Articles By RheumNow
Medical Societies to CMS: Not Ready for Stage 3 Meaningful Use
Dozens of medical societies pressed the Centers for Medicare and Medicaid Services (CMS) to temporarily halt implementation of the final stage of Meaningful Use, a program that rewards and penalizes clinicians based on how effectively they use electronic medical records.
Read ArticleArthritis and Poverty: Chicken or Egg?
The development of arthritis is an underappreciated reason why individuals become impoverished -- a finding that was particularly pronounced for women, an Australian study found.
Read ArticleA Rule of Five Spots Spine Disease
A combined rule of five -- the presence of at least five fatty lesions/erosions in the sacroiliac (SI) joint, at least five fatty lesions in the spine, or at least five spinal inflammatory lesions on magnetic resonance imaging (MRI) -- is highly specific for axial spondyloarthritis in patients wi
Read ArticlePoll: Americans Favor Federal Action on Drug Prices
Most Americans value the prescription products the drug industry produces, but they sure don't like the prices and want the federal government to take action, according to a new survey
Read ArticleCV Risk in RA: Is a New Measurement Tool the Answer?
A new expanded cardiovascular (CV) risk calculator for use in patients with rheumatoid arthritis (RA) has been developed to take into account disease-specific factors that can worsen risk, researchers reported.
Read ArticleAllopurinol Risky in Asian Population
The go-to drug to treat hyperuricemia and gout, allopurinol, put patients at risk for developing hypersensitivity when American College of Rheumatology guidelines weren't followed, a large database study found.
Read ArticleTroponin and BNP in the Diagnosis of Pulmonary Hypertension
Common cardiac biomarkers could be used to identify patients with systemic sclerosis (SSc) at risk for developing pulmonary hypertension, French researchers reported.
Read Article